PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint ##### Up next ![Creating a Future of "All-Sustainable"](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2024/10/Michelin_s_unique_technical_capabilities.jpg?resize=200%2C110&ssl=1 "Creating a Future of "All-Sustainable"") [](https://thailandbusinessnews.net/press-release/creating-a-future-of-all-sustainable/) ###### [Creating a Future of "All-Sustainable"](https://thailandbusinessnews.net/press-release/creating-a-future-of-all-sustainable/) Published on 28 October 2024 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) PROVISION Study demonstrates significant economic and resource utilization advantages in FFRangio cohort compared to invasive wire-based FFR cohort WASHINGTON, Oct. 28, 2024 /PRNewswire/ — Today at the Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place at the Walter E. Washington Convention Center in Washington, DC, investigators from Gifu Heart Center and Fukuoka Sanno Hospital presented the results of the physician-initiated PROVISION1 Study. The investigators shared the first randomized controlled trial (RCT) of FFRangio outcomes compared to invasive wire-based fractional flow reserve (FFR) has met its primary endpoint and revealed significant economic and resource utilization advantages for the non-invasive FFRangio technology over traditional wire-based approaches. [![PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint](https://mma.prnasia.com/media2/2541276/CathWorks_PressReleaseCard_OCT27_V1.jpg?p=medium600 "PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint")](https://mma.prnasia.com/media2/2541276/CathWorks_PressReleaseCard_OCT27_V1.jpg?p=medium600) PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint The PROVISION Study included the enrollment of 400 patients across 13 centers in Japan. The principal investigators, Professor Hitoshi Matsuo from Gifu Heart Center and Professor Hiroyoshi Yokoi from Fukuoka Sanno Hospital, aimed to confirm that the physiological assessment with the wire-free angiography-based CathWorks FFRangio® System yields the same clinical treatment plans as those based on evaluation performed with invasive wire-based FFR, with no difference in their clinical prognoses. Additionally, the study aims to show that FFRangio offers economic advantages over wire-based FFR. The FFRangio System combines artificial intelligence (AI) and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree. The PROVISION Study is the first Japanese prospective RCT comparing the outcomes of an angio-based physiology technology in comparison to invasive wire-based physiology. Patients with intermediate coronary lesions (30-90% diameter stenosis) were randomized 1:1 to either the wire-based FFR arm, in which the treatment decision was determined based on FFR values obtained using an invasive pressure wire, or the FFRangio arm, in which the treatment decision was based on FFRangio values. Based on the functional evaluations, either revascularization (PCI) and optimal medical management (OMT) or OMT alone were selected. For patients who underwent PCI, a post-PCI physiological assessment was performed using the respective technology, and patients will be followed clinically for at least one year. Professor Yokoi shared, "The results from the post-PCI assessments performed on patients who underwent PCI and OMT, planned to be analyzed and reported after the completion of one-year follow-up, can provide the very much needed insight on optimal cut-off(s) for post-PCI FFR values, and provide the clinical evidence necessary to encourage routine post-PCI physiology assessment." Professor Matsuo stated, "The results of this study are groundbreaking for coronary artery disease diagnostics in Japan. FFRangio offers a non-invasive alternative that not only matches the diagnostic accuracy of traditional wire-based FFR but also improves operational efficiencies and reduces costs for healthcare providers." Key findings from the study include: Primary Endpoint Achieved: FFRangio showed a similar revascularization rate by demonstrating non-inferiority of proportion test using a binary variable, confirming its value as a non-invasive diagnostic tool. Economic Advantages: The study showed a significant reduction in overall costs of ~$374 and $400, respectively in OMT and PCI cohorts for FFRangio compared to invasive wire-based FFR. Resource Utilization Improvements: FFRangio required fewer catheterization lab resources, including reduced radiation dose, which translated to increased efficiency compared to invasive wire-based FFR. Patient Comfort and Safety: As a non-invasive approach, FFRangio reduces the need for pressure wires and hyperemic agents, minimizing patient discomfort and potential complications. CathWorks President & CEO Ramin Mousavi added, "This significant milestone validates our mission of transforming how coronary artery disease is diagnosed and treatment through innovation. The results from the PROVISION Study have officially kicked off a new era in physiology, underscoring FFRangio as the new standard of care and potential to drive better patient outcomes while delivering tangible economic and resource utilization benefits to healthcare systems." ABOUT CATHWORKS CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio® System combines artificial intelligence and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree. For more information on CathWorks, visit [www.cath.works](https://c212.net/c/link/?t=0&l=en&o=4287889-1&h=3535598398&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3645704-1%26h%3D269289650%26u%3Dhttp%253A%252F%252Fwww.cath.works%26a%3Dwww.cath.works&a=www.cath.works) and follow [@CathWorks](https://c212.net/c/link/?t=0&l=en&o=4287889-1&h=495002297&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3645704-1%26h%3D3939395205%26u%3Dhttps%253A%252F%252Ftwitter.com%252FCathWorks%26a%3D%2540CathWorks&a=%40CathWorks) on [X](https://c212.net/c/link/?t=0&l=en&o=4287889-1&h=1932467313&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3645704-1%26h%3D793970463%26u%3Dhttps%253A%252F%252Ftwitter.com%252Fcathworks%253Flang%253Den%26a%3DTwitter&a=X) and [LinkedIn](https://c212.net/c/link/?t=0&l=en&o=4287889-1&h=1944318828&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3645704-1%26h%3D2135856311%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fcathworks%252Fjobs%26a%3DLinkedIn&a=LinkedIn). 1\. Prospective Randomized trial of clinical Outcomes of angiography-based fractional flow reserve guidance Versus wIre-baSed fractIOnal flow reserve guidance (PROVISION) study is an investigation of the Utility of Coronary Angiography (FFRangio) in Comparison to Coronary Fractional Flow Reserve (FFR) in the Determination of Treatment Planning and the Clinical Prognosis in Patients with Chronic Phase Coronary Artery Disease Investors:Mike Feher Media:Sarita Monico Photo – [https://mma.prnasia.com/media2/2541276/CathWorks\_PressReleaseCard\_OCT27\_V1.jpg?p=medium600](https://c212.net/c/link/?t=0&l=en&o=4287889-1&h=960738015&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2541276%2FCathWorks_PressReleaseCard_OCT27_V1.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2541276%2FCathWorks_PressReleaseCard_OCT27_V1.jpg) [Source link ](https://www.prnasia.com/story/archive/4541114_AE41114_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/dk88-casino-officially-launches-in-malaysia/) ![DK88 Casino Officially Launches in Malaysia](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2026/02/DK88-Casino-Officially-Launches-in-Malaysia.jpg?resize=260%2C140&ssl=1 "DK88 Casino Officially Launches in Malaysia") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## DK88 Casino Officially Launches in Malaysia < p style=”text-align: justify”>KUALA LUMPUR, Feb 21, 2026 – (ACN Newswire) –?DK88… - [ACN Newswire](https://thailandbusinessnews.net/author/acnnewswire/ "View all posts by ACN Newswire") - February 24, 2026 [](https://thailandbusinessnews.net/press-release/depths-of-understanding/) ![Depths of understanding](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/12/658131dca31040acaf82e14a.jpg?resize=260%2C140&ssl=1 "Depths of understanding") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Depths of understanding BEIJING, Dec. 20, 2023 /PRNewswire/ — A news report from chinadaily.com.cn: Shipwreck provides… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - December 20, 2023 [](https://thailandbusinessnews.net/press-release/lumicore-champions-micro-oled-display-technology-for-better-immersive-experiences/) ![Lumicore Champions Micro-OLED Display Technology for Better Immersive Experiences](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2024/02/Lumicore_s_1_32_micro_OLED_production_base.jpg?resize=260%2C140&ssl=1 "Lumicore Champions Micro-OLED Display Technology for Better Immersive Experiences") - [Press Release](https://thailandbusinessnews.net/category/press-release/) - [Tech](https://thailandbusinessnews.net/category/tech/) ## Lumicore Champions Micro-OLED Display Technology for Better Immersive Experiences SHANGHAI, Feb. 2, 2024 /PRNewswire/ — Lumicore, the leading manufacturer of high-resolution,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - February 2, 2024 ##### Most Read - [![DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") [DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") - [![Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") [Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") - [![ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") [ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") - [![Everest Medicines Announces Interim Results for First Half of 2026](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") [Everest Medicines Announces Interim Results for First Half of 2026](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") - [![GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") [GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") - [![Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/taiwantrade-com-brings-taiwans-ict-excellence-to-computex-2025/ "Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025") [Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025](https://thailandbusinessnews.net/press-release/taiwantrade-com-brings-taiwans-ict-excellence-to-computex-2025/ "Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/yunji-announces-first-half-2026-unaudited-financial-results/) ## Yunji Announces First Half 2026 Unaudited Financial Results HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ — Yunji Inc. ("Yunji" or… [](https://thailandbusinessnews.net/press-release/sharon-ai-successfully-delivers-ai-cloud-deployment-for-global-technology-customer/) ## Sharon AI Successfully Delivers AI Cloud Deployment for Global Technology Customer NEW YORK, Aug. 20, 2026 /PRNewswire/ — SharonAI Holdings Inc. (NASDAQ: SHAZ)… [](https://thailandbusinessnews.net/press-release/matwings-demonstrates-closed-loop-protein-ai-through-four-ai-wet-lab-cycles-and-222-protein-variants/) ## Matwings Demonstrates Closed-Loop Protein AI Through Four AI-Wet Lab Cycles and 222 Protein Variants The GenSci148 program illustrates a shift from one-time mutation prediction to… [](https://thailandbusinessnews.net/press-release/the-boy-from-baby-shark-dance-starts-a-new-wave-with-debut-single-wave-featuring-joohoney-of-monsta-x/) ![The Boy from Baby Shark Dance Starts a New Wave with Debut Single "WAVE," Featuring JOOHONEY of MONSTA X](https://i0.wp.com/mmx.prnasia.com/media/MS1972930/20260820035234EDT_image_1.jpg?resize=260%2C140&ssl=1 "The Boy from Baby Shark Dance Starts a New Wave with Debut Single "WAVE," Featuring JOOHONEY of MONSTA X") ## The Boy from Baby Shark Dance Starts a New Wave with Debut Single "WAVE," Featuring JOOHONEY of MONSTA X "WAVE" reimagines the iconic Baby Shark melody as an energetic electropop…